Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infection Asymptomatic”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Not applicableStudy completedNCT03009032
What this trial is testing

Synbiotics in Advanced HIV Infection

Who this might be right for
HIV Infection Asymptomatic
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 77
Early research (Phase 1)Study completedNCT00000667
What this trial is testing

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00002350
What this trial is testing

A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients

Who this might be right for
HIV Infections
Apollon 16
Large-scale testing (Phase 3)Study completedNCT00002109
What this trial is testing

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

Who this might be right for
HIV Infections
Immunobiology Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT04840199
What this trial is testing

Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Who this might be right for
HIV InfectionsCytomegalovirusCMV
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT00348673
What this trial is testing

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

Who this might be right for
HIV-1
Pfizer 49
Not applicableEnded earlyNCT02839603
What this trial is testing

Asymptomatic Leishmania Infection in HIV Patients

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 540
Large-scale testing (Phase 3)Study completedNCT00000736
What this trial is testing

Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,200
Large-scale testing (Phase 3)Study completedNCT00000750
What this trial is testing

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Early research (Phase 1)Study completedNCT00480558
What this trial is testing

MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Who this might be right for
HIV InfectionsTB
University of Oxford 48
Not applicableStudy completedNCT00031057
What this trial is testing

Vitamin B Therapy for Hyperlactatemia

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 225
Not applicableStudy completedNCT00002048
What this trial is testing

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Who this might be right for
Lymphatic DiseaseHIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00495677
What this trial is testing

PF-00232798 In HIV Positive Patients

Who this might be right for
HIV
Pfizer 43
Testing effectiveness (Phase 2)UnknownNCT01067417
What this trial is testing

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

Who this might be right for
HIV Infections
Medical Research Council 83
Testing effectiveness (Phase 2)Study completedNCT00848211
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Thymon, LLC 24
Not applicableStudy completedNCT00002260
What this trial is testing

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Who this might be right for
HIV Infections
Lederle Laboratories
Not applicableLooking for participantsNCT07312266
What this trial is testing

Questioning the Epidemiology of Asymptomatic TB

Who this might be right for
TuberculosisTuberculosis (TB)HIV+1 more
Barcelona Institute for Global Health 6,770
Early research (Phase 1)Study completedNCT00000762
What this trial is testing

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableStudy completedNCT00002271
What this trial is testing

An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Who this might be right for
HIV Infections
Lederle Laboratories
Load More Results